Aclarion, Inc.
$3.55
▲
4.69%
2026-04-21 05:03:01
www.aclarion.com
NCM: ACON
Explore Aclarion, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$7.74 M
Current Price
$3.55
52W High / Low
$12.03 / $2.34
Stock P/E
—
Book Value
$15.02
Dividend Yield
—
ROCE
-54.95%
ROE
-1.05%
Face Value
—
EPS
$-13.61
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
—
Beta
1.14
Debt / Equity
—
Current Ratio
14.81
Quick Ratio
14.81
Forward P/E
-0.24
Price / Sales
97.35
Enterprise Value
$-4.65 M
EV / EBITDA
0.68
EV / Revenue
-61.45
Rating
None
Target Price
$7
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Weave Communications, Inc. | $5.47 | — | $430.21 M | — | -24.81% | -37.56% | $11.32 / $4.24 | $1.05 |
| 2. | Privia Health Group, Inc. | $24.08 | 131.66 | $3.02 B | — | 4.27% | 4.03% | $26.51 / $18.77 | $5.96 |
| 3. | National Research Corporation | $18.18 | 35.65 | $413.53 M | 3.52% | 22.99% | 51.24% | $22.79 / $9.76 | $0.62 |
| 4. | Definitive Healthcare Corp. | $1.05 | — | $147.1 M | — | -3.56% | -40.42% | $4.7 / $0.92 | $2.7 |
| 5. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
| 6. | TruBridge, Inc. | $23.18 | 77.96 | $339.43 M | — | 6.05% | 2.52% | $26.74 / $13.88 | $12.25 |
| 7. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.02 M | 0.02 M | 0.02 M | 0.02 M | 0.01 M | — |
| Operating Profit | -1.99 M | -1.83 M | -1.74 M | -1.49 M | -1.81 M | — |
| Net Profit | -1.89 M | -1.71 M | -1.6 M | -2.04 M | -1.99 M | — |
| EPS in Rs | -0.83 | -0.75 | -0.7 | -0.89 | -0.87 | -1,321.49 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.08 M | 0.05 M | 0.08 M | 0.06 M |
| Operating Profit | -7.05 M | -5.51 M | -4.88 M | -5.56 M |
| Net Profit | -7.23 M | -6.99 M | -4.91 M | -7.07 M |
| EPS in Rs | -3.17 | -3.06 | -2.15 | -3.1 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 13.67 M | 2.12 M | 2.46 M | 2.91 M |
| Total Liabilities | 0.84 M | 1.15 M | 3.19 M | 0.69 M |
| Equity | 12.84 M | 0.97 M | -0.73 M | 2.23 M |
| Current Assets | 12.4 M | 0.82 M | 1.29 M | 1.7 M |
| Current Liabilities | 0.84 M | 1.15 M | 3.19 M | 0.69 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -7.16 M | -5.27 M | -3.65 M | -4.95 M |
| Investing CF | -0.2 M | -0.32 M | -0.12 M | -0.21 M |
| Financing CF | 18.95 M | 5.03 M | 3.31 M | 6.19 M |
| Free CF | -7.37 M | -5.59 M | -3.77 M | -5.16 M |
| Capex | -0.2 M | -0.32 M | -0.12 M | -0.21 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -39.36% | 24.75% | — | — |
| Earnings Growth % | -42.38% | 30.52% | — | — |
| Profit Margin % | -15293.78% | -6513.41% | -11694.45% | — |
| Operating Margin % | -12057.23% | -6467.99% | -9202.51% | — |
| Gross Margin % | -85.15% | -0.43% | -8.03% | — |
| EBITDA Margin % | -13700.29% | -5490.98% | -8962.72% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-03-28 | 1:0.037037 |
| 2025-01-30 | 1:0.00298507 |
| 2024-01-04 | 1:0.0625 |